{"symbol": "MEIP", "companyName": "MEI Pharma Inc.", "exchange": "NASDAQ Capital Market", "industry": "Drug Manufacturers", "website": "http://www.meipharma.com", "description": "MEI Pharma Inc is an oncology company focused on the clinical development of novel therapeutics for cancer. The Company's portfolio of drug candidates includes Pracinostat, an oral histone deacetylase inhibitor.", "CEO": "Daniel P. Gold", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Drug Manufacturers - Specialty & Generic", "Drug Manufacturers"]}